Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review.

Bierman WF, van Agtmael MA, Nijhuis M, Danner SA, Boucher CA.

AIDS. 2009 Jan 28;23(3):279-91. doi: 10.1097/QAD.0b013e32831c54e5. Review.

PMID:
19114854
2.

Ritonavir-boosted protease inhibitor monotherapy for the treatment of HIV-1 infection.

Sahali S, Chaix ML, Delfraissy JF, Ghosn J.

AIDS Rev. 2008 Jan-Mar;10(1):4-14. Review.

PMID:
18385776
3.

[Lopinavir/ritonavir monotherapy. Possible indications].

López Aldeguer J.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:21-3. Review. Spanish.

PMID:
19572440
4.

Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients.

Youle M.

J Antimicrob Chemother. 2007 Dec;60(6):1195-205. Epub 2007 Sep 21. Review.

PMID:
17890281
5.

Monotherapy with lopinavir/ritonavir.

Schechter M, Nunes EP.

Expert Opin Investig Drugs. 2007 May;16(5):735-41. Review.

PMID:
17461744
6.

[Lopinavir/ritonavir monotherapy as a simplification strategy in antiretroviral therapy in clinical practice].

Moltó J, Clotet B.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:24-6. Review. Spanish.

PMID:
19572441
7.

[Lopinavir/ritonavir monotherapy as a simplification strategy in the treatment of HIV-1 infection].

Pulido Ortega F, Llenas-García J.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:12-20. Review. Spanish.

PMID:
19572439
9.

Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment.

Barragan P, Podzamczer D.

Expert Opin Pharmacother. 2008 Sep;9(13):2363-75. doi: 10.1517/14656566.9.13.2363 . Review.

PMID:
18710360
10.

Boosted protease inhibitor monotherapy. What have we learnt after seven years of research?

Pulido F, Matarranz M, Rodríguez-Rivera V, Fiorante S, Hernando A.

AIDS Rev. 2010 Jul-Sep;12(3):127-34. Review.

PMID:
20842201
11.

Protease inhibitor monotherapy as maintenance regimen in patients with HIV infection.

Calza L, Manfredi R.

Curr HIV Res. 2012 Dec;10(8):661-72. Review.

PMID:
23016538
12.

[Monotherapy in treatment-naïve patients].

Arranz Caso JA.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:2-7. Review. Spanish.

PMID:
19572437
13.

[Lopinavir/ritonavir monotherapy for the treatment of HIV-1 infection: the emergence of resistance].

Delgado R.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:34-40. Review. Spanish.

PMID:
19572443
14.

[Prognostic factors of virological response in patients treated with lopinavir/ritonavir monotherapy].

Pérez Valero I.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:27-33. Review. Spanish.

PMID:
19572442
15.

Protease inhibitor monotherapy.

Pérez-Valero I, Arribas JR.

Curr Opin Infect Dis. 2011 Feb;24(1):7-11. doi: 10.1097/QCO.0b013e3283422cdf. Review.

PMID:
21150592
16.

A review of low-dose ritonavir in protease inhibitor combination therapy.

Cooper CL, van Heeswijk RP, Gallicano K, Cameron DW.

Clin Infect Dis. 2003 Jun 15;36(12):1585-92. Epub 2003 Jun 5. Review.

PMID:
12802760
17.

Fosamprenavir calcium plus ritonavir for HIV infection.

Torres HA, Arduino RC.

Expert Rev Anti Infect Ther. 2007 Jun;5(3):349-63. Review.

PMID:
17547501
18.

Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients.

Zeldin RK, Petruschke RA.

J Antimicrob Chemother. 2004 Jan;53(1):4-9. Epub 2003 Dec 4. Review.

PMID:
14657084
19.
20.

Predictors of virologic response to ritonavir-boosted protease inhibitors.

Marcelin AG, Flandre P, Peytavin G, Calvez V.

AIDS Rev. 2005 Oct-Dec;7(4):225-32. Review.

PMID:
16425962

Supplemental Content

Support Center